IT1229765B - New immunogenic cpds. for synthetic vaccines for Plasmodium malariae - Google Patents
New immunogenic cpds. for synthetic vaccines for Plasmodium malariaeInfo
- Publication number
- IT1229765B IT1229765B IT8920553A IT2055389A IT1229765B IT 1229765 B IT1229765 B IT 1229765B IT 8920553 A IT8920553 A IT 8920553A IT 2055389 A IT2055389 A IT 2055389A IT 1229765 B IT1229765 B IT 1229765B
- Authority
- IT
- Italy
- Prior art keywords
- lysine
- cpds
- immunogenic
- contg
- pref
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 3
- 241000223821 Plasmodium malariae Species 0.000 title abstract 2
- 229940118768 plasmodium malariae Drugs 0.000 title abstract 2
- 229940126577 synthetic vaccine Drugs 0.000 title 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 3
- 235000019766 L-Lysine Nutrition 0.000 abstract 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 2
- 239000004472 Lysine Substances 0.000 abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
- 238000002965 ELISA Methods 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- 241000223810 Plasmodium vivax Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229940124280 l-arginine Drugs 0.000 abstract 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Immunogenic cpds. of formula (I), and acid or basic addn. salts are new. D is L-lysine or branched poly (L-lysine) with a number n of L-lysine aminoacid residues of alpha and epsilon amide linkages; n is odd integer from 1-15 (pref. 3-7); m is integer from 3-40 (pref. 6-15); R1 is side chain of aminoacid residue from L-Asp, L-His, L-Cys, L-Gln, L-Thr, L-Ala, L-Leu, L-Met, L-Phe, L-Glu, L-Arg, L-Tyr, L-Asn, L-Ser, L-Gly, L-Val, L-Ile, L-Pro, and L-Trp; R2 is OH or NH2; R is H or acyl radical. An immunogenic cpd. (I) is claimed contg. hapten(s) specifically (NNAP)r or (DRAD(AGQPAG)r (r = 3-40). (I) may also be used for determining Plasmodium malariae antibodies in human blood, specifically by ELISA. A vaccine is also claimed against Plasmodium vivax contg. (I) and an appropriate hapten.
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8920553A IT1229765B (en) | 1989-05-19 | 1989-05-19 | New immunogenic cpds. for synthetic vaccines for Plasmodium malariae |
| DK90201244.2T DK0398443T3 (en) | 1989-05-19 | 1990-05-16 | Immunogenic compounds and their use in the preparation of genetically unrestricted synthetic vaccines and for the immunoenzymatic determination of antisporozoite antibodies against Plasmodium malariae |
| DE69014150T DE69014150T2 (en) | 1989-05-19 | 1990-05-16 | Immunogen compounds and their use in the production of genetically unrestricted synthetic vaccines and in the immunoenzymatic determination of antisporozoid antibodies from Plasmodium malariae. |
| AT90201244T ATE114158T1 (en) | 1989-05-19 | 1990-05-16 | IMMUNOGEN COMPOUNDS AND THEIR USE IN THE PRODUCTION OF GENETICALLY UNRESTRICTED SYNTHETIC VACCINES AND IN THE IMMUNOENZYMATIC DETERMINATION OF ANTISPOROZOID ANTIBODIES OF PLASMODIUM MALARIAE. |
| ES90201244T ES2063901T3 (en) | 1989-05-19 | 1990-05-16 | IMMUNOGENOUS COMPOUNDS AND THEIR USE IN THE PREPARATION OF GENETICALLY RESTRICTED SYNTHETIC VACCINES AND IN THE IMMUNOENZYMATIC DETERMINATION OF ANTIESPOROZOITE ANTIBODIES OF PLASMODIUM MALARIAE. |
| EP90201244A EP0398443B1 (en) | 1989-05-19 | 1990-05-16 | Immunogenic compounds and their use in the preparation of genetically unrestricted synthetic vaccines and in the immunoenzymatic determination of antisporozoite antibodies of plasmodium malariae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8920553A IT1229765B (en) | 1989-05-19 | 1989-05-19 | New immunogenic cpds. for synthetic vaccines for Plasmodium malariae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8920553A0 IT8920553A0 (en) | 1989-05-19 |
| IT1229765B true IT1229765B (en) | 1991-09-10 |
Family
ID=11168684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT8920553A IT1229765B (en) | 1989-05-19 | 1989-05-19 | New immunogenic cpds. for synthetic vaccines for Plasmodium malariae |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1229765B (en) |
-
1989
- 1989-05-19 IT IT8920553A patent/IT1229765B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| IT8920553A0 (en) | 1989-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL179617A0 (en) | Method of stabilizing proteins | |
| RU2014108829A (en) | INJECTION ACCEPTABLE SOLUTION AT LEAST ONE BASAL INSULIN | |
| MX9301753A (en) | IN VITRO GENERATION OF HUMAN DENTRITIC CELLS AND THE USE OF THE SAME. | |
| DE69636891D1 (en) | IMMUNOSTIMULATING COMPOSITION AND METHOD | |
| CA2480672A1 (en) | Suction sequences for a breastpump | |
| RU2008126305A (en) | NEW PEPTID | |
| DE69913687T2 (en) | A VLA-4 inhibitor: oMePUPA-V | |
| AU2002329256A1 (en) | Methods of rna and protein synthesis | |
| CY1111718T1 (en) | COMPOSITIONS AND METHODS FOR DENSITY CELL-BASED IMMUNOLOGY | |
| CY1107681T1 (en) | USE OF PRODUCERS THROUGHOUT TO PRODUCE MEDICINES | |
| IT1229765B (en) | New immunogenic cpds. for synthetic vaccines for Plasmodium malariae | |
| WO2002088328A3 (en) | Method for generating highly active human dendritic cells from monocytes | |
| FR2846974A1 (en) | Producing substances in Escherichia, useful particularly for preparing amino acids, by culturing a bacterium in which the FIS protein, involved in nucleoid formation, is inactivated | |
| GR3018750T3 (en) | Immunogenic compounds, the process for their synthesis and their use in the preparation of antimalaria vaccines | |
| CY1113871T1 (en) | GABAPENTINI PREPARATION PROCEDURE | |
| AU5493296A (en) | 6-carboxamido dihydropyran derivatives | |
| TR200501541T2 (en) | Signal sequences of the dissociation of Leu-hirudin with e.coli in culture medium | |
| DE60215627D1 (en) | VACCINATOR FOR MODULATION BETWEEN T1 AND T2 IMMUNE RESPONSES | |
| IT1241081B (en) | Immunogenic compounds and their use for the preparation of genetically unrestricted synthetic vaccines for the immunoenzymatic determination of anti-plasmodium malariae sporozoite antibodies | |
| DK0398443T3 (en) | Immunogenic compounds and their use in the preparation of genetically unrestricted synthetic vaccines and for the immunoenzymatic determination of antisporozoite antibodies against Plasmodium malariae | |
| WO2024011186A3 (en) | Antibodies and methods of making and using same | |
| MX2025005727A (en) | Oral care compositions | |
| EP1667634A4 (en) | Anthrax vaccine | |
| AR005119A1 (en) | PROCEDURE FOR THE PREPARATION OF THE INTERMEDIATE COMPOUND N-ACETIL (L) -4-CIANOFENILALANINA AC- (L) -PHE (4-CN) -OH PARTICULARLY USEFUL IN THE PREPARATION OF N-ACETIL- (L) -P-AMIDINOFENILALANINA-CICLOHEXILGLICINA -BETA- (3-N-METHYLPYRIDINY) ALANINE AND PROCEDURE FOR THE PREPRATION OF THE COMPOUND N-ACETYL- (L) -P-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCIN-BETA- (3-N-METHYLPYRIDINY) ALANINE | |
| DK1578772T3 (en) | Cytokines and cytokine receptors with reduced immunogenicity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970515 |